Ligases Enzyme Global Market Report 2024

Ligase enzymes, a class of proteins essential for facilitating the union of two DNA strands, play a pivotal role in biotechnology and pharmaceuticals. Their significance extends to various cellular processes, notably DNA replication and protein synthesis.

Key types of ligase enzyme products include E. coli DNA ligase, T4 DNA ligase, mammalian ligases, and thermostable ligases. E. coli DNA ligase specifically refers to an enzyme sourced from Escherichia coli (E. coli) bacteria. These ligases are derived from diverse organisms, including microorganisms, animals, and plants. They are integral to a multitude of techniques, encompassing ligase chain reaction (LCR), ligase detection reaction (LDR), next-generation sequencing (NGS), repeat expansion detection (RED), rolling circle amplification (RCA), proximity ligation assay (PLA), molecular cloning, ligation-mediated PCR, and mutation detection. These versatile applications cater to a broad spectrum of end-users, including research laboratories and institutions, pharmaceutical and biopharmaceutical companies, as well as diagnostic laboratories.

The ligases enzyme market research report is one of a series of new reports from The Business Research Company that provides ligases enzyme market statistics, including ligases enzyme industry global market size, regional shares, competitors with a ligases enzyme market share, detailed ligases enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the ligases enzyme industry. This ligases enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. 

The ligases enzyme market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.21 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth observed in the historic period of ligase enzymes can be attributed to several factors. Initially, the discovery and development of ligase enzymes played a crucial role in their increased utilization. Additionally, the growth of the biotechnology industry provided a conducive environment for the advancement and application of ligase enzymes. A heightened understanding of DNA repair mechanisms further contributed to their significance in various cellular processes. The expansion of genetic engineering applications, facilitated by ligase enzymes, also played a role in their increased demand. Lastly, the rise in demand for molecular diagnostics, where ligase enzymes find application, further fueled their growth during this historic period.

The ligases enzyme market size is expected to see rapid growth in the next few years. It will grow to $4.92 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth during the forecast period can be ascribed to the expanding applications of personalized medicine, a heightened emphasis on synthetic biology, the increasing use of ligase enzymes in drug development, a rising demand for molecular diagnostics, and the integration of ligases in next-generation sequencing. Key trends in the forecast period encompass the development of engineered ligases tailored for specific applications, the incorporation of ligase enzymes in CRISPR-based technologies, the customization of ligase-based assays for both research and diagnostics, the emergence of ligase-based isothermal amplification methods, and the adoption of ligase chain reaction (LCR) in diagnostic assays.

The anticipated growth of the ligase enzyme market is attributed to the increasing prevalence of cancer and genetic disorders. Cancer, characterized by uncontrolled cell growth, and genetic disorders, resulting from abnormalities or mutations in genetic material, particularly DNA, are on the rise. Ligase enzymes, crucial for DNA replication, repair, and recombination, play a pivotal role in these conditions. In cancer, ligases repair damaged DNA, contributing to uncontrolled cell growth, while in genetic disorders, ligases can be utilized to target and eliminate affected cells. Notably, in 2020, the Centers for Disease Control and Prevention reported 1,603,844 new cancer cases and 602,347 related deaths in the United States. Additionally, Gene People UK revealed that 1 in 25 children in the UK is affected by a genetic condition, with over 2.4 million individuals living with such disorders.

An upsurge in research and development (R&D) activities is expected to drive the ligase enzyme market's growth. Ligase enzymes, also known as DNA ligases, are essential tools in joining DNA molecules-a critical aspect of various R&D endeavors across diverse fields. For instance, in 2020, the National Center for Science and Engineering Statistics reported a total of $717.0 billion spent on R&D in the United States, with an estimated $791.9 billion for 2021. This increase in R&D investment underscores the significance of ligase enzymes in advancing scientific and technological innovations, thereby fueling the growth of the ligase enzyme market.

Product innovation is emerging as a notable trend in the ligase enzyme market, with major companies actively pursuing the development of novel ligases to solidify their market positions. A prime example is ArcticZymes Technologies ASA, a Norway-based biotechnology firm, which unveiled the ArcticZymes R2D Ligase in December 2021. This patent-pending ligase demonstrates unique specificity, allowing the ligation of DNA to both ends of RNA using a DNA splint. Anticipated to have broad applications in molecular diagnostics, next-generation sequencing, and gene/RNA synthesis for potential therapeutic uses, this enzyme stands out for its high activity and efficiency, making it suitable for diverse applications.

Strategic partnerships are also becoming a focal point for major companies in the ligase enzyme market. Lonza Group, a Switzerland-based company operating in the pharmaceutical, biotechnology, and nutrition sectors, formed a partnership with Singzyme, a Singapore-based company specializing in enzyme development, in September 2021. This collaboration grants Lonza access to Singzyme's enzymatic conjugation platform, enabling site-specific binding of payloads with peptidic linkers to proteins-particularly advantageous for precision medicine applications such as cancer treatment. The ligase-specific tag sequence-based technique ensures versatility in handling various payload types and shorter development timescales.

In May 2022, QIAGEN N.V., a Germany-based provider of molecular testing solutions, acquired a majority stake in BLIRT S.A., a Poland-based biotechnology company known for manufacturing specialty ligase enzymes and reagents. This strategic acquisition is aimed at expanding QIAGEN's sample technology business by leveraging BLIRT's technology and expertise, thereby reinforcing QIAGEN's position in the life science industry. This strategic maneuver underscores the importance of inorganic growth strategies for gaining a competitive edge in the dynamic ligase enzyme market.

Major companies operating in the ligases enzyme market report are BASF SE, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Novo Holdings AS, GenScript, VWR International, R And D Systems Inc., Promega Corporation, Oxford Nanopore Technologies Limited, Takara Bio Inc., New England Biolabs Inc., BioVision Inc., Enzo Life Sciences, Zymo Research, LGC Biosearch Technologies, Genetix Biotech Asia Pvt. Ltd., BLIRT S.A., Jena Bioscience, Bioline, Creative Enzymes, ArcticZymes Technologies ASA

North America was the largest region in the ligases enzyme market in 2023. Asia-Pacific is expected to be the fastest-growing region in the ligases enzyme market report during the forecast period. The regions covered in the ligases enzyme market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ligases enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ligases enzyme market consists of sales of hi-t4 DNA ligase, splintR ligase, salt-t4 DNA ligase, t7 DNA ligase, quick ligation kits, Taq DNA ligase, and electroLigase. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ligases Enzyme Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ligases enzyme market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ligases enzyme ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ligases enzyme market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: E. coli DNA ligase; T4 DNA Ligase; Mammalian Ligases; Thermostable Ligases
• 2) By Source: Microorganisms; Animal; Plant
• 3) By Application: Ligase Chain Reaction (LCR); Ligase Detection Reaction (LDR); Next-Generation Sequencing (NGS); Repeat Expansion Detection (RED); Rolling Circle Amplification (RCA); Proximity Ligation Assay (PLA); Molecular Cloning; Ligation Mediated PCR; Mutation Detection
• 4) By End-User: Research Laboratories And Institutions; Pharmaceutical And Biopharmaceutical Companies; Diagnostic Laboratories
• Companies Mentioned: BASF SE; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson And Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.